Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe.
about
Annona muricata (Annonaceae): A Review of Its Traditional Uses, Isolated Acetogenins and Biological ActivitiesProtection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's diseaseChemicals possessing a neurotrophin-like activity on dopaminergic neurons in primary cultureConsiderations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiologyMelatonin ameliorates brain injury induced by systemic lipopolysaccharide in neonatal rats.Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.The neurodegenerative mitochondriopathies.Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study.Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity.REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy.Piericidin A aggravates Tau pathology in P301S transgenic miceNeonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life.Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?Interleukin-1 receptor antagonist reduces neonatal lipopolysaccharide-induced long-lasting neurobehavioral deficits and dopaminergic neuronal injury in adult rats.Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancerCelecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide.Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study.Neonatal exposure to lipopolysaccharide enhances accumulation of α-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later lifeNeurodegenerative diseases: neurotoxins as sufficient etiologic agents?Neonatal systemic exposure to lipopolysaccharide enhances susceptibility of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life.Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies.A phenotypic model recapitulating the neuropathology of Parkinson's disease.Mitochondrial therapies for Parkinson's disease.Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.The Annona muricata leaf ethanol extract affects mobility and reproduction in mutant strain NB327 Caenorhabditis elegans.A novel thiophene-3-carboxamide analog of annonaceous acetogenin exhibits antitumor activity via inhibition of mitochondrial complex I.Annonaceae: Breaking the Wall of Inflammation.Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease.Emerging therapeutic potential of graviola and its constituents in cancers.The Oxygen Paradox, the French Paradox, and age-related diseases.Exploring the Leaves of Annona muricata L. as a Source of Potential Anti-inflammatory and Anticancer Agents.
P2860
Q26800000-323EA2A3-8D04-455C-A0D4-91B5302C644AQ27302176-56E434C2-F95E-4637-9496-F44DA180F839Q28475734-BAA17CA5-1234-41AB-A59D-10F84CF39635Q33603777-65691EDF-5A60-40C2-994E-ACE96CE06BC5Q33677273-DB0870FB-CA56-4645-939D-E77335951976Q33761048-75924A3D-B060-4BC7-9E4E-9CFEBF2AB36DQ33957065-2DF218D3-2004-4D40-86DA-95536765DECEQ34198178-B6FFC566-39AD-498C-8CB4-6D827C5F3BA0Q34510971-5EAD9CE7-7CFA-4C8A-8677-7C96404D86BEQ34581908-5C51E90D-0F8E-42B5-84EB-1E390559C25EQ34600121-E6300550-345D-48C8-831D-4FAAFAAB6632Q35255816-E73B9248-C77D-4D35-8A33-504807A8F055Q35412397-3AC3BE98-93C5-4B1C-A7EA-23FF0D17C034Q35585714-80A11C41-E7DA-40A2-B6AC-D50059242400Q36049419-A64153F9-E26D-48CC-A38A-3D940FC94402Q36798371-8B6C5ADC-F619-4DEA-B40F-211F31FF4F74Q36885365-9FECADC5-79B2-43C1-8FD3-F66F941936ECQ36913314-2F353738-5E12-4B72-81A6-CDB1C35218C6Q36994301-2F497761-6109-427E-9F52-241963D753DCQ37182878-02717F88-DB33-444E-8DCD-F75D6D52EEBCQ37211755-BD6091D0-547B-46CC-A406-6884118C0C90Q37407288-6258DAD3-7D88-4117-A52E-CF4360451114Q37699222-874F1AA2-495E-4EBB-8C15-5E1C149EA34FQ38021865-45473111-D938-4B36-9933-0EA6B9E2591FQ41682166-E5911FD7-6D44-4116-9078-61259D26D256Q41895590-D8555AFA-74AC-497B-8567-787DA98D7467Q46268493-35616975-D42A-418F-B182-0B0A4F78CA68Q47147993-09882EC1-F91B-49FA-A911-3E244908357BQ53178012-74F41435-B88A-4A56-A192-9472FCCF63A3Q55384244-9C8044A9-14D4-4911-B468-BD0937560477Q55512594-678A89DD-E85C-40AE-BAC6-3A91F0FA9A48
P2860
Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Annonacin, a lipophilic inhibi ...... al parkinsonism in Guadeloupe.
@ast
Annonacin, a lipophilic inhibi ...... al parkinsonism in Guadeloupe.
@en
type
label
Annonacin, a lipophilic inhibi ...... al parkinsonism in Guadeloupe.
@ast
Annonacin, a lipophilic inhibi ...... al parkinsonism in Guadeloupe.
@en
prefLabel
Annonacin, a lipophilic inhibi ...... al parkinsonism in Guadeloupe.
@ast
Annonacin, a lipophilic inhibi ...... al parkinsonism in Guadeloupe.
@en
P2093
P921
P1476
Annonacin, a lipophilic inhibi ...... al parkinsonism in Guadeloupe.
@en
P2093
Alain Laurens
Anne Lombès
Annie Lannuzel
Christophe Gleye
Etienne C Hirsch
Fadia Medja
Günter U Höglinger
Jean Féger
Merle Ruberg
Olivier Laprévote
P407
P577
2004-01-01T00:00:00Z